Verena Kalter

879 total citations
8 papers, 148 citations indexed

About

Verena Kalter is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Verena Kalter has authored 8 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Verena Kalter's work include Chronic Lymphocytic Leukemia Research (5 papers), Immune Cell Function and Interaction (3 papers) and Phagocytosis and Immune Regulation (2 papers). Verena Kalter is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Immune Cell Function and Interaction (3 papers) and Phagocytosis and Immune Regulation (2 papers). Verena Kalter collaborates with scholars based in Germany, Austria and United Kingdom. Verena Kalter's co-authors include Peter Lichter, Martina Seiffert, John G. Gribben, Bola S. Hanna, Alexander Egle, Fabienne McClanahan, Nadja Zaborsky, Axel Benner, Michael A. Rogers and Selcen Öztürk and has published in prestigious journals such as Blood, Leukemia and Cancers.

In The Last Decade

Verena Kalter

8 papers receiving 148 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verena Kalter Germany 6 80 79 44 39 31 8 148
Sven Turkalj United Kingdom 5 39 0.5× 40 0.5× 47 1.1× 31 0.8× 31 1.0× 9 114
Stuart J. Blakemore United Kingdom 7 42 0.5× 53 0.7× 97 2.2× 25 0.6× 28 0.9× 9 155
Annalisa D’Avola United Kingdom 8 69 0.9× 91 1.2× 65 1.5× 21 0.5× 67 2.2× 13 159
Pauline Robbe United Kingdom 5 42 0.5× 91 1.2× 34 0.8× 25 0.6× 88 2.8× 14 137
Jared Henderson United States 5 48 0.6× 45 0.6× 38 0.9× 55 1.4× 52 1.7× 14 131
Maité Cabes United Kingdom 5 39 0.5× 100 1.3× 41 0.9× 47 1.2× 96 3.1× 10 139
Jennifer A. Arzt United States 4 27 0.3× 65 0.8× 64 1.5× 52 1.3× 58 1.9× 5 151
Olga Stehlíková Czechia 7 52 0.7× 56 0.7× 51 1.2× 22 0.6× 40 1.3× 14 146
Grégory Lazarian France 5 70 0.9× 176 2.2× 34 0.8× 54 1.4× 136 4.4× 17 203
Sandra Graß Germany 6 38 0.5× 61 0.8× 55 1.3× 22 0.6× 44 1.4× 11 152

Countries citing papers authored by Verena Kalter

Since Specialization
Citations

This map shows the geographic impact of Verena Kalter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Kalter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Kalter more than expected).

Fields of papers citing papers by Verena Kalter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Kalter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Kalter. The network helps show where Verena Kalter may publish in the future.

Co-authorship network of co-authors of Verena Kalter

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Kalter. A scholar is included among the top collaborators of Verena Kalter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Kalter. Verena Kalter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Öztürk, Selcen, Irene Gil-Fariña, Anna Jauch, et al.. (2021). Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients. Leukemia. 36(2). 464–475. 6 indexed citations
2.
Öztürk, Selcen, Verena Kalter, Philipp M. Roessner, Murat Sünbül, & Martina Seiffert. (2021). IDO1-Targeted Therapy Does Not Control Disease Development in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia. Cancers. 13(8). 1899–1899. 8 indexed citations
3.
Öztürk, Selcen, Manuela Zucknick, Axel Benner, et al.. (2019). Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia. Cancers. 11(6). 822–822. 7 indexed citations
4.
Hanna, Bola S., Murat Iskar, Norman Mack, et al.. (2017). IL-10 Receptor Deficiency Aggravates Exhaustion of CD8+ T-Cells and Impedes Their Control of Chronic Lymphocytic Leukemia. Blood. 130. 385–385. 2 indexed citations
5.
Rogers, Michael A., Verena Kalter, Moritz J. Strowitzki, Martin Schneider, & Peter Lichter. (2016). IGF2 knockdown in two colorectal cancer cell lines decreases survival, adhesion and modulates survival-associated genes. Tumor Biology. 37(9). 12485–12495. 8 indexed citations
6.
Hanna, Bola S., Fabienne McClanahan, Nadja Zaborsky, et al.. (2015). Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo. Leukemia. 30(3). 570–579. 101 indexed citations
7.
Rogers, Michael A., et al.. (2015). CITED4 gene silencing in colorectal cancer cells modulates adherens/tight junction gene expression and reduces cell proliferation. Journal of Cancer Research and Clinical Oncology. 142(1). 225–237. 15 indexed citations
8.
Hanna, Bola S., Fabienne McClanahan, Nadja Zaborsky, et al.. (2014). Targeting Dysfunctional Myeloid Cells Delays Disease Development and Improves Immune Function in a CLL Mouse Model. Blood. 124(21). 3298–3298. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026